COVID-19 and Clinical Trials: Current Challenges and Future Directions

Area of Science:

• Clinical Research
• Pandemic Response
• Health Technology

Background:

• The coronavirus disease (COVID-19) pandemic significantly impacted global health and daily life.
• Clinical trial activities faced unprecedented disruptions at research sites worldwide.
• The pandemic necessitated a re-evaluation of standard clinical trial operations.

Purpose of the Study:

• To assess the impact of the COVID-19 pandemic on ongoing clinical trials.
• To identify challenges encountered in clinical trial execution during the pandemic.
• To explore innovative strategies for managing clinical trials in a disrupted environment.

Main Methods:

• A comprehensive literature search was conducted to evaluate the status of ongoing clinical trials.
• Clinical trial portals were included in the assessment.
• Observations from the literature and portals formed the basis of the evaluation.

Main Results:

• Clinical trials faced significant challenges including patient recruitment and retention.
• Ensuring the safety of trial subjects and maintaining protocol compliance were major concerns.
• The pandemic forced a reconsideration of strategies for conducting clinical trials.

Conclusions:

• Digitalization presents a viable path forward for clinical trial management.
• Virtual management of adverse events and remote monitoring visits are key digital strategies.
• Web-based consulting with trial subjects can enhance global clinical trial operations.